This document provides an overview of obesity, including its definition, measurement, prevalence, causes, evaluation, treatment approaches, and a case study. It defines obesity as a BMI over 30 kg/m2 and notes the increased prevalence in the US and worldwide. The evaluation of patients with obesity involves taking a history, physical exam, assessing comorbidities, fitness, and readiness to change. Treatment options include lifestyle management, pharmacotherapy, and surgery. A case study is then presented and discussed in terms of appropriate treatment goals.
Obesity - Pathophysiology, Etiology and management Aneesh Bhandary
Obesity is a state of excess adipose tissue mass. A massive psychosocial, pathophysiological problem that results in a high rate of mortality as well as morbidity. The basic mechanisms of the illness and its management as of 2017 are described in this presentation
Obesity - Pathophysiology, Etiology and management Aneesh Bhandary
Obesity is a state of excess adipose tissue mass. A massive psychosocial, pathophysiological problem that results in a high rate of mortality as well as morbidity. The basic mechanisms of the illness and its management as of 2017 are described in this presentation
The health hazards associated with obesity. Mortality morbidity
Complications related to obesity
type 2 diabetes.
high blood pressure.
heart disease and strokes.
certain types of cancer.
sleep apnea.
osteoarthritis.
fatty liver disease.
This ppt contains all the details about what is obesity, etiology, & mainly focuses on various methods of assessment of obesity from field tests to lab tests.
Obesity is defined as an abnormal growth of the adipose tissue and or enlargement of fat cell size (hypertrophic obesity) or increase in fat cell number (hyperplastic obesity).
Obesity is often expressed in terms of body mass index (BMI)
Are you Struggling to Control of your Diabetes and Weight?
People who are overweight or obese are more prone to developing Type 2 diabetes. Those who have Type 1 and Type 2 diabetes with weight problems struggle to control their blood sugar levels. Research shows that people with diabetes find it more difficult to lose weight than those without diabetes.
Weight loss significantly improves blood sugar control and also reduces the risk of getting complications from diabetes. However, whilst attempting to lose weight, people with diabetes find it hard to restrict their intake of food since eating less may trigger hypoglycaemia (low blood sugar). All these facts explain the need for specialist input in management of weight in people with diabetes.
This Slideshow gives you insight to Diabesity
For more information please visit
http://www.simplyweight.co.uk
Articles
http://www.simplyweight.co.uk/articles/
Videos
http://www.simplyweight.co.uk/video/
Blogs
http://simplyweight.co.uk/blogs/
Forum
http://www.simplyweight.co.uk/forum/forum.php
Contact Us
http://www.simplyweight.co.uk/how-to-contact-us/
"48 SLIDES???!!", my friends shouted.
A boring "48 slides" is depend on how you arrange it. And this is not the one for sure.
I always love to prepare a short and sweet presentation. Or maybe long but sweet presentation? Oh yeah! Enjoy!
#SLIDESKILLSvsSLIDEKILLS
The health hazards associated with obesity. Mortality morbidity
Complications related to obesity
type 2 diabetes.
high blood pressure.
heart disease and strokes.
certain types of cancer.
sleep apnea.
osteoarthritis.
fatty liver disease.
This ppt contains all the details about what is obesity, etiology, & mainly focuses on various methods of assessment of obesity from field tests to lab tests.
Obesity is defined as an abnormal growth of the adipose tissue and or enlargement of fat cell size (hypertrophic obesity) or increase in fat cell number (hyperplastic obesity).
Obesity is often expressed in terms of body mass index (BMI)
Are you Struggling to Control of your Diabetes and Weight?
People who are overweight or obese are more prone to developing Type 2 diabetes. Those who have Type 1 and Type 2 diabetes with weight problems struggle to control their blood sugar levels. Research shows that people with diabetes find it more difficult to lose weight than those without diabetes.
Weight loss significantly improves blood sugar control and also reduces the risk of getting complications from diabetes. However, whilst attempting to lose weight, people with diabetes find it hard to restrict their intake of food since eating less may trigger hypoglycaemia (low blood sugar). All these facts explain the need for specialist input in management of weight in people with diabetes.
This Slideshow gives you insight to Diabesity
For more information please visit
http://www.simplyweight.co.uk
Articles
http://www.simplyweight.co.uk/articles/
Videos
http://www.simplyweight.co.uk/video/
Blogs
http://simplyweight.co.uk/blogs/
Forum
http://www.simplyweight.co.uk/forum/forum.php
Contact Us
http://www.simplyweight.co.uk/how-to-contact-us/
"48 SLIDES???!!", my friends shouted.
A boring "48 slides" is depend on how you arrange it. And this is not the one for sure.
I always love to prepare a short and sweet presentation. Or maybe long but sweet presentation? Oh yeah! Enjoy!
#SLIDESKILLSvsSLIDEKILLS
power point presentation on obesity by Rajeshwaree Netha (Doctor of pharmacy).
contents included are Introduction,pathophyisiology,clinical presentation (signs and symptoms of obesity disorder) ,Treatment,goals of treatment, general approach, Pharmacological treatment, and Evaluation of therapeutic outcomes.
DEFINITION AND MEASUREMENT Obesity is a state of excess adipose tissue mass. Although often viewed as equivalent to increased body weight, this need not be the case—lean but very muscular individuals may be overweight by numerical standards without having increased adiposity.
Body mass index (BMI), which is equal to weight/height2 (in kg/m2 )
Body weights are distributed continuously in populations, so that choice of a medically meaningful distinction between lean and obese is somewhat arbitrary. Obesity is therefore defined by assessing its linkage to morbidity or mortality
Weight gain and physical activity in mid life world menopause dayManinder Ahuja
it is for awareness about Role of exercise and life style modifications in Healthy Aging. This would prevent metabolic syndromes and Diabetes, Hypertension , CHD , Cancers and many problems of mid life beyond years.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
2. DEFINITION AND MEASUREMENT
Obesity is a state of excess adipose tissue mass
current practical definition of obesity is determined by an assessment of
BMI. (Obesity is >30 kg/m2)
BMI is calculated by dividing a person’s weight (in kilograms) / height (in
meters squared);
alternatively, the [weight (in pounds) *704 ] /height (in inches squared)
3.
4. •PREVELANCE
• BMI >30 has increased from 14.5% to 35.7% - U.S
• Women – 6.6%
• Men – 3.5%
• more common among blacks and Hispanics.
• worldwide prevalence :more than doubled in less than 35 years
India
5. • Study Facts:
• World Population: 7,505,257,673
• World Obesity Population : 774,000,000
9. EVALUATION
• (1) a focused obesity-related history,
• (2) a physical examination to determine the degree and type of obesity,
• (3) assessment of comorbid conditions,
• (4) determination of fitness level, and
• (5) assessment of the patient’s readiness to adopt lifestyle changes.
10. The Obesity-Focused History
• What factors contribute to the patient’s obesity?
• How is the obesity affecting the patient’s health?
• What is the patient’s level of risk from obesity?
11. • What does the patient find difficult about managing weight?
• What are the patient’s goals and expectations?
• Is the patient motivated to begin a weight management program?
• What kind of help does the patient need?
12. Factors Affecting Body Mass Index–Related Risk
• The relationship between BMI and health risk is influenced by,
• body fat distribution,
• age,
• concomitant medical illness,
• weight gain,
• aerobic fitness, and
• ethnicity.
13. •CAUSES
• Role of genes Versus Environment
• Genetic
• Obesity is commonly seen in families, and the heritability of body weight is
similar to that for height.
• Environmental
• viruses
• sleep deprivation
19. •Body Mass Index (BMI) and Waist Circumference
• Three key anthropometric measurements are important in evaluating the
degree of obesity:
• weight,
• height, and
• waist circumference (102 in men and 88 in women).
20. •Physical Fitness
Several prospective studies have demonstrated that physical fitness, measured
by a maximal treadmill exercise test, is an important predictor of all-cause
mortality rate independent of BMI and body composition.
25. Assessing the Patient’s Readiness to Change
• patient motivation and support,
• stressful life events,
• psychiatric status,
• time availability and constraints,
• and appropriateness of goals and expectations.
26. Readiness can be viewed as the balance of two opposing forces:
• (1) motivation, or the patient’s desire to change; and
• (2) resistance, or the patient’s resistance to change.
• A helpful method to begin a readiness assessment is to use the motivational
interviewing technique of “anchoring” the patient’s interest and confidence to
change on a numerical scale.
27. TREATMENT
• THE GOAL OF THERAPY
• The primary goals of treatment are to improve obesity-related comorbid
conditions and to reduce the risk of developing future comorbidities.
• Target: 8–10% over 6 months
39. Case Presentation
• A 45-year-old white woman presents with difficulty losing weight
despite her diet and exercises program.
• She feels she is a setup for T2DM, which her mother developed when
she was the patient’s age.
• She states she was never very thin, but she has been gradually gaining
weight over the last 10 years.
40. • She attributes her weight gain to decreased physical activity and stress-
induced eating.
• She has lost 15 to 20lb on several occasions on various diet programs, but
she stops following the diet when she does not see continued progress and
then she regains her weight.
• The heaviest she ever weighed was 210lb.
• Her primary physician started her on amlodipine10mg o.d for her HTN this
past year, but she is otherwise in good health.
41. • GPE,
• B.P :130/85mm Hg.
• Weight : 200lb
• Height : 5’4”.
• W.C : 38’
• HC : 40”
• She did not have any striae, bruising, or significant hirsutism.
• She had a normal cervical fat pad for her weight.
• Her abdomen was obese with weight distribution more typical of an android
body shape
42. • Laboratory findings
• FPG : 105mg/dL,
• HbA1c : 5.5%.
• Total cholesterol -198mg/dL,
• HDL -39mg/dL,
• triglycerides -200mg/dL,
• LDL - 110mg/dL.
• TSH - 1.6IU/mL,
• 24-hoururine free cortisol- 50g/24 hours.
• The patient wants to know what she can do to lose weight and reduce her risk
of developing diabetes.
43. • BMI = 34.3
• Determine the appropriate risk of metabolic syndrome
WC or waist-to-hip ratio provides the measure of central obesity
• Weight management therapy one step further beyond the initial 5% to 10%,
• To set an appropriate goal for weight to reduce the risk of metabolic
syndrome, physicians must inform patients of where they stand on the
cardiovascular disease risk curve and what they need to do to reduce the risk
to where it is more comparable to someone without significant obesity .
• This is accomplished by reducing this patient’s BMI from her initial 34 down
to 27 or 28
44. • Setting the ideal body weight range as the appropriate goal is not realistic for
someone with significant obesity.
• An over aggressive goal only leads to weight management failure.
• Many weight loss attempts fail because people do not transition well from the
weight loss phase to the weight maintenance phase.
• caloric restriction and exercises to increase their energy expenditure in order
to maintain the weight loss.
45. REFERENCES
• HARRISON’S PRINCIPLES OF INTERNAL MEDICINE 19TH EDITION.
• WILLIAM TEXTBOOK OF ENDOCRINOLOGY 13TH EDITION
• API TEXTBOOK OF MEDICINE . EDITOR-IN-CHIEF YASH PAL MUNJ
9th EDITION
• A CASE-BASED GUIDE TO CLINICAL ENDOCRINOLOGY TERRY F.
DAVIES, MD, FRCP, FACE
46. • CROSS REFERENCES
• Management of Obesity .Anoop Misra, Lokesh Khurana
• European Guidelines for Obesity Management in Adults .Volkan Yumuk
Constantine Tsigos Martin Fried et.al
• Update on Treatment Strategies for Obesity.Holly R. Wyatt
• Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the
Metabolic Syndrome for Asian Indians and Recommendations for Physical
Activity, Medical and Surgical Management A Misra*, P Chowbey**, BM
Makkar***,
• Obesity: Current Treatment andFuture Horizons.Article in Mini
Reviews in Medicinal Chemistry · January 2017
• Identification, assessment, and management of overweight and obesity:
summary of updated NICE guidance